Increasing unusual option volume: ISEE AVCT SGFY HEAR TECS CS ING HNST
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Stifel Reiterates Buy Rating on Iveric Bio (ISEE) as Zimura 'Checks All Efficacy AND Safety Boxes'
September 6, 2022 12:14 PM EDTStifel analyst Annabel Samimy reiterated a Buy rating and $28.00 price target on Iveric Bio (NASDAQ: ISEE) following the release of GATHER-2 (G2) Zimura data that hit high statistical significance on its primary endpoint of mean rate of GA growth (slope) for both square root transformation and... More
Iveric Bio (ISEE) PT Raised to $30 at Cowen; Zimura Has Solid Profile in Likely $4B+ Market
September 6, 2022 11:16 AM EDTCowen analyst Ken Cacciatore raised the price target on Iveric Bio (NASDAQ: ISEE) to $30.00 (from $25.00) while maintaining a Outperform rating following Zimura results, saying it has a solid profile in likely $4B+ market.
The analyst commented, "Iveric bio disclosed positive results from Zimura's... More
Iveric Bio (ISEE) PT Raised to $27 at Credit Suisse
September 6, 2022 10:33 AM EDTCredit Suisse analyst Tiago Fauth raised the price target on Iveric Bio (NASDAQ: ISEE) to $27.00 (from $24.00) while maintaining a Outperform rating.
The analyst comments "Competitive Dynamic Nuanced, but Valuation Gap Still Favors ISEE Shares. We expect the debate to now shift to... More
